官方服务：
资源简介：
Faster insulin aspart in type 1 diabetes mellitus
应用场景：
创建时间：
2022-03-31
相关数据集
Continuous insulin therapy versus multiple insulin injections in the management of type 1 diabetes: a longitutinal study
Abstract Objective: To compare multiple doses of insulin and continuous insulin infusion therapy as treatment for type 1 diabetes mellitus. Methods: 40 patients with type 1 diabetes mellitus (21 fem
NIAID Data Ecosystem80
GDF15: a potential therapeutic target for type 1 diabetes
Current treatment for type 1 diabetes (T1D) is centered around insulin supplementation to manage the effects of pancreatic β cell loss. GDF15 is a potential preventative therapy against T1D progressio
NIAID Data Ecosystem30
A transgene coding for a human insulin analog has a mitogenic effect on murine embryonic beta cells.
We have investigated the mitogenic effect of three mutant forms of human insulin on insulin-producing beta cells of the developing pancreas. We examined transgenic embryonic and adult mice expressing
PubMed Central1995-07-03 更新20
Global Insulin Biosimilars Market Size, Share, Growth Analysis, By Type(Fast-acting Insulin, Intermediate-acting Insulin), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies), By Indication(Diabetes Type 1, and Diabetes Type 2) - Industry Forecast 2024-2031
Global Insulin Biosimilars Market size was valued at USD 2.67 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 4.07 billion by 2031, growing at a CAGR of 4.8% in the forecast
www.skyquestt.com70
Islet Transplantation in Type 1 Diabetes (CIT-07) and Extended Follow Up after Islet Transplantation in Type 1 Diabetes (CIT-08)
CIT-07: The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, for treating type 1 diabetes in individuals experi
Immunology Database and Analysis Portal2025-10-30 更新20
